Related Experiment Videos
Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia
Clinical and Experimental Immunology
|June 1, 1983
Summary
Pyoderma gangrenosum patients with paraproteinemia may have defective monocyte phagocytosis. This defect, linked to paraprotein levels, improved with treatment and recurred upon relapse.
Area of Science:
- Immunology
- Dermatology
- Hematology
Background:
- Pyoderma gangrenosum (PG) is a rare inflammatory skin disease.
- Monoclonal gammopathy is associated with various autoimmune and inflammatory conditions.
- The pathogenesis of PG in the context of monoclonal gammopathy is not fully understood.
Observation:
- Peripheral blood monocytes from a PG patient with paraproteinemia exhibited defective phagocytosis.
- The phagocytic defect correlated with paraprotein levels and clinical activity of PG.
- Treatment with Melphalan reduced paraprotein, induced PG remission, and normalized monocyte function.
Findings:
- Recurrence of elevated paraprotein levels was associated with a return of the monocyte defect and PG.
- Normal monocytes incubated with the patient's plasma or IgG fractions showed induced phagocytic defects.
- The patient's serum displayed anti-heparin activity, prompting exploration of its role in the phagocytic defect.
Implications:
- Suggests a potential pathogenetic mechanism linking PG and monoclonal gammopathy.
- Highlights the role of specific immunoglobulin abnormalities in immune cell dysfunction.
- Provides a basis for further research into targeted therapies for PG associated with paraproteinemia.